ACCLA!M ANTICHOLINERGIC LAS 34273 COPD CLINICAL TRIAL ASSESSING EFFICACY AND SAFETY IN MODERATE TO SEVERE COPD PATIENTS

Welcome to the Brand page for “ACCLA!M ANTICHOLINERGIC LAS 34273 COPD CLINICAL TRIAL ASSESSING EFFICACY AND SAFETY IN MODERATE TO SEVERE COPD PATIENTS”, which is offered here for The mark consists of the term acclaim in white with a green exclamation symbol forming the letter i. the words anticholinergic las 34273 appear in blue below the term acclaim with the letters a and c in green and against a white banner. the term copd appears to the right of these terms in white. the terms clinical trial assessing efficacy and safety in moderate to severe copd patients appear at the bottom of the mark in white with the letters c, 1, a, i, and m in green. the background of the mark is the color blue.;acclaim anticholinergic las 34273 copd clinical trial assessing efficacy and safety in moderate to severe copd patients;the color(s) blue, green and white is/are claimed as a feature of the mark.;anticholinergic las 34273 copd clinical trial assessing efficacy and safety in moderate to severe copd patients;medical and scientific research, clinical trials for pharmaceuticals to treat respiratory diseases;.

Its status is currently believed to be active. Its class is unavailable. “ACCLA!M ANTICHOLINERGIC LAS 34273 COPD CLINICAL TRIAL ASSESSING EFFICACY AND SAFETY IN MODERATE TO SEVERE COPD PATIENTS” is believed to be currently owned by “ALMIRALL, S.A.”